3P Biopharmaceuticals and the American biotech company, Zhittya Genesis Medicine (Zhittya), have successfully accomplished the process transfer and GMP supply of FGF-1 candidate.
Read moreHan demostrado que el tratamiento con un fármaco de diseño que modifica el procesado del ARN puede ralentizar la neurodegeneración típica de la esclerosis lateral amiotrófica (ELA). Sus resultado...
Read moreThey have evaluated the efficacy of soluble low-density lipoprotein receptor 1 (sLRP1) as an indicator of carotid plaque inflammation.
Read moreA study in which IDIBAPS researchers took part has found new alterations that cause loss of function in the BMPR2 gene, leading to uncontrolled proliferation of the epithelial cells of the colon and a...
Read moreGenerating new memories and remembering are two sides of the same coin, although sometimes they can appear as separate mechanisms. These mechanisms which seem to be distanced from each other are actua...
Read moreResearchers are leading a pioneering study that aims to determine whether a blood test can provide information about the brain of people with neurological dysfunctions like autism. This test would ena...
Read moreHan desarrollado una calculadora que identifica los pacientes con mieloma múltiple y amiloidosis sistémica primaria que presentan mejor pronóstico al tener un perfil más benigno.
Read moreMineralys Therapeutics today announced the first patient dosed in the ADVANCE-HTN pivotal trial to evaluate the safety and efficacy of lorundrostat for the treatment of uncontrolled hypertension (uHTN...
Read moreEl Instituto de Investigación del Hospital de la Santa Creu i Sant Pau – IIB Sant Pau ha desarrollado un nuevo medicamento de inmunoterapia CAR-T que acaba de empezar a administrar, en el marco de ...
Read moreA new neuroscientific study using magnetoencephalography, a fast brain imaging technique, found that turbulence provides the key mechanism underlying the efficient spatiotemporal information transfer ...
Read moreA phase III clinical trial comparing the efficacy the combination of Trifluridine/tipiracil plus the antibody bevacizumab versus Trifluridine/tipiracil in patients with refractory metastatic colonrect...
Read moreEl estudio, publicado en NPJ Vaccines, demuestra que estas partículas pueden ser útiles como vacuna terapéutica o preventiva contra el VIH
Read more